BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21624563)

  • 21. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.
    Wolk DA; Zhang Z; Boudhar S; Clark CM; Pontecorvo MJ; Arnold SE
    J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):923-6. PubMed ID: 22791901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
    Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
    Nucl Med Biol; 2005 Nov; 32(8):799-809. PubMed ID: 16253804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease.
    Liu Y; Zhu L; Plössl K; Choi SR; Qiao H; Sun X; Li S; Zha Z; Kung HF
    Nucl Med Biol; 2010 Nov; 37(8):917-25. PubMed ID: 21055622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of PET-imaging probes of β-amyloid plaques.
    Koo J; Byun Y
    Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid PET Imaging: Standard Procedures and Semiquantification.
    D'Amico F; Sofia L; Bauckneht M; Morbelli S
    Methods Mol Biol; 2024; 2785():165-175. PubMed ID: 38427194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain.
    Watanabe H; Ono M; Kimura H; Kagawa S; Nishii R; Fuchigami T; Haratake M; Nakayama M; Saji H
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6519-22. PubMed ID: 21920750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making.
    Zannas AS; Doraiswamy PM; Shpanskaya KS; Murphy KR; Petrella JR; Burke JR; Wong TZ
    Neurocase; 2014 Aug; 20(4):466-73. PubMed ID: 23672654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
    Rinne JO; Wong DF; Wolk DA; Leinonen V; Arnold SE; Buckley C; Smith A; McLain R; Sherwin PF; Farrar G; Kailajärvi M; Grachev ID
    Acta Neuropathol; 2012 Dec; 124(6):833-45. PubMed ID: 23053137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
    Siderowf A; Pontecorvo MJ; Shill HA; Mintun MA; Arora A; Joshi AD; Lu M; Adler CH; Galasko D; Liebsack C; Skovronsky DM; Sabbagh MN
    BMC Neurol; 2014 Apr; 14():79. PubMed ID: 24716655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
    Landau SM; Breault C; Joshi AD; Pontecorvo M; Mathis CA; Jagust WJ; Mintun MA;
    J Nucl Med; 2013 Jan; 54(1):70-7. PubMed ID: 23166389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
    J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Yousefi BH; Manook A; Drzezga A; von Reutern B; Schwaiger M; Wester HJ; Henriksen G
    J Med Chem; 2011 Feb; 54(4):949-56. PubMed ID: 21275403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo staging of regional amyloid deposition.
    Grothe MJ; Barthel H; Sepulcre J; Dyrba M; Sabri O; Teipel SJ;
    Neurology; 2017 Nov; 89(20):2031-2038. PubMed ID: 29046362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
    Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
    Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
    Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.
    Newberg AB; Arnold SE; Wintering N; Rovner BW; Alavi A
    J Nucl Med; 2012 Jun; 53(6):902-7. PubMed ID: 22577238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.
    Dugger BN; Clark CM; Serrano G; Mariner M; Bedell BJ; Coleman RE; Doraiswamy PM; Lu M; Fleisher AS; Reiman EM; Sabbagh MN; Sadowsky CH; Schneider JA; Zehntner SP; Carpenter AP; Joshi AD; Mintun MA; Pontecorvo MJ; Skovronsky DM; Sue LI; Beach TG
    J Neuropathol Exp Neurol; 2014 Jan; 73(1):72-80. PubMed ID: 24335535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
    Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.